Northrop Grumman (NOC) Stock Forecast & Price Target

Northrop Grumman is supported by a strong mix of program execution, budget visibility, and improving growth momentum, with 3Q26 adjusted EPS of $7.89 beating estimates by about 10% and sales rising 7% to $11.1B. The company’s record backlog of $109.6B, 1.5x book-to-bill, and $16.4B in net awards provide durable revenue visibility, while key programs such as B-21, Sentinel, and F-35-related work are well supported in the FY27 base budget request. Management’s 2027 outlook for 5%–7% sales growth, positive growth across all four segments, and $3.3B–$3.7B in FCF, alongside potential international expansion and microelectronics optionality, reinforces the positive fundamental case.

Northrop Grumman is facing a negative setup because its upside catalysts are narrowing after losing F/A-XX to Boeing, while the remaining B-21, space, and solid rocket motor opportunities require incremental investment that will pressure free cash flow and near-term margins. The company’s growth profile is now viewed as largely in line with peers, with about 6% top-line growth through 2028 and limited margin expansion, yet its valuation still embeds a premium that could compress toward historical averages. In addition, slower budget growth in FY28 and broader uncertainty around defense spending, capital deployment, and program execution limit re-rating potential and reduce the likelihood of a sustained earnings multiple expansion.